{"answers":{"affected":"","exploited":"There is no known exploitation of CVE-2026-50034 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2026-50034 yet. Limit exposure of the affected software until one is available.","what":"CVE-2026-50034 is a high-severity vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim."},"fix_prompt":"Check this codebase for CVE-2026-50034 and fix it if it is affected.\n\nWhat it is: CVE-2026-50034 is a high-severity vulnerability in Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT), published on 18 Jun 2026. It can only be exploited from the same machine or local network, with no action from the victim.\nExploitation: There is no known exploitation of CVE-2026-50034 in the wild and no public exploit code.\n\nAffected product: Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT). No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2026-50034/ (Markdown: https://insights.sbomify.com/CVE-2026-50034/index.md)","id":"CVE-2026-50034","markdown":"https://insights.sbomify.com/CVE-2026-50034/index.md","name":"CVE-2026-50034","record":{"aliases":["GHSA-cmv8-9pgg-5rx4"],"analysis":{"component_type":"iot_embedded","fix_type":"no_fix_stated","impacts":["data_read"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"Blood Glucose Monitor","requires_auth":"none","summary":"Attackers within Bluetooth range can intercept cleartext traffic to steal sensitive glucose measurement data from the device.","user_interaction":"not_required","vuln_class":"information_disclosure"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"icscert","cpe":[],"cvss":{"score":7.1,"severity":"high","source":"cna","vector":"CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N","version":"4.0"},"cwes":[{"id":"CWE-319","name":"Cleartext Transmission of Sensitive Information"}],"description":"An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values.","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information","id":"CVE-2026-50034","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"information_disclosure","year":"2026"},"n_packages":0,"n_references":4,"next":{"headline":"Stack-based Buffer Overflow in MZ Automation libIEC61850","id":"CVE-2026-50039"},"packages":[],"prev":{"headline":"Privilege escalation in Acronis DeviceLock DLP","id":"CVE-2026-50033"},"products":["Blood Glucose Monitoring System (Model No. APG-01 BT)"],"published":"2026-06-18","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"partial"},"state":"PUBLISHED","updated":"2026-06-22","vendors":["Apollo Pharmacy"]},"summary":"Attackers within Bluetooth range can intercept cleartext traffic to steal sensitive glucose measurement data from the device.","url":"https://insights.sbomify.com/CVE-2026-50034/"}